Magnolol and honokiol: potential lead compounds for the new drug discovery in treating autoimmune diseases
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1578971/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850201258934140928 |
|---|---|
| author | Xian Lin Xian Lin Xian Lin Jian Chen Jian Chen Jian Chen |
| author_facet | Xian Lin Xian Lin Xian Lin Jian Chen Jian Chen Jian Chen |
| author_sort | Xian Lin |
| collection | DOAJ |
| format | Article |
| id | doaj-art-a11e737b2f4c451eab9f577b739e0816 |
| institution | OA Journals |
| issn | 1663-9812 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj-art-a11e737b2f4c451eab9f577b739e08162025-08-20T02:12:03ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-04-011610.3389/fphar.2025.15789711578971Magnolol and honokiol: potential lead compounds for the new drug discovery in treating autoimmune diseasesXian Lin0Xian Lin1Xian Lin2Jian Chen3Jian Chen4Jian Chen5Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen, ChinaInstitute of Immunology and Inflammatory Diseases, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, ChinaShenzhen Key Laboratory of Inflammatory and Immunology Diseases, Shenzhen, ChinaDepartment of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen, ChinaInstitute of Immunology and Inflammatory Diseases, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, ChinaShenzhen Key Laboratory of Inflammatory and Immunology Diseases, Shenzhen, Chinahttps://www.frontiersin.org/articles/10.3389/fphar.2025.1578971/fullmagnololhonokiolautoimmune diseasesrheumatoid arthritislead compound |
| spellingShingle | Xian Lin Xian Lin Xian Lin Jian Chen Jian Chen Jian Chen Magnolol and honokiol: potential lead compounds for the new drug discovery in treating autoimmune diseases Frontiers in Pharmacology magnolol honokiol autoimmune diseases rheumatoid arthritis lead compound |
| title | Magnolol and honokiol: potential lead compounds for the new drug discovery in treating autoimmune diseases |
| title_full | Magnolol and honokiol: potential lead compounds for the new drug discovery in treating autoimmune diseases |
| title_fullStr | Magnolol and honokiol: potential lead compounds for the new drug discovery in treating autoimmune diseases |
| title_full_unstemmed | Magnolol and honokiol: potential lead compounds for the new drug discovery in treating autoimmune diseases |
| title_short | Magnolol and honokiol: potential lead compounds for the new drug discovery in treating autoimmune diseases |
| title_sort | magnolol and honokiol potential lead compounds for the new drug discovery in treating autoimmune diseases |
| topic | magnolol honokiol autoimmune diseases rheumatoid arthritis lead compound |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2025.1578971/full |
| work_keys_str_mv | AT xianlin magnololandhonokiolpotentialleadcompoundsforthenewdrugdiscoveryintreatingautoimmunediseases AT xianlin magnololandhonokiolpotentialleadcompoundsforthenewdrugdiscoveryintreatingautoimmunediseases AT xianlin magnololandhonokiolpotentialleadcompoundsforthenewdrugdiscoveryintreatingautoimmunediseases AT jianchen magnololandhonokiolpotentialleadcompoundsforthenewdrugdiscoveryintreatingautoimmunediseases AT jianchen magnololandhonokiolpotentialleadcompoundsforthenewdrugdiscoveryintreatingautoimmunediseases AT jianchen magnololandhonokiolpotentialleadcompoundsforthenewdrugdiscoveryintreatingautoimmunediseases |